A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
作者信息
Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-Estrada R
机构信息
Dermatology Department. Hospital, Universitario y Politécnico La Fe. Valencia, Spain.
School of Medicine, Universitat de València, Valencia, Spain.
出版信息
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e537-e539. doi: 10.1111/jdv.16664. Epub 2020 Jul 2.
Abstract
摘要
相似文献
1
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e537-e539. doi: 10.1111/jdv.16664. Epub 2020 Jul 2.
2
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
Dermatol Ther. 2020 May;33(3):e13380. doi: 10.1111/dth.13380. Epub 2020 Apr 16.
3
Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e536-e537. doi: 10.1111/jdv.16663. Epub 2020 Jul 2.
4
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
Dermatol Ther. 2020 Jul;33(4):e13565. doi: 10.1111/dth.13565. Epub 2020 May 26.
5
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
J Med Case Rep. 2020 Nov 3;14(1):210. doi: 10.1186/s13256-020-02504-8.
6
Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2777-2779.e1. doi: 10.1016/j.jaip.2020.05.046. Epub 2020 Jun 7.
7
An Isolated Peculiar Gianotti-Crosti Rash in the Course of a COVID-19 Episode.
Acta Derm Venereol. 2020 Sep 30;100(16):adv00276. doi: 10.2340/00015555-3641.
8
Eosinophilic granulomatosis with polyangiitis mimicking coronavirus disease 2019: a case report.
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e557-e559. doi: 10.1111/jdv.16705. Epub 2020 Jun 29.
9
COVID-19 and Cutaneous manifestations.
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):e246. doi: 10.1111/jdv.16483. Epub 2020 Jun 11.
10
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
Am J Dermatopathol. 2021 May 1;43(5):342-348. doi: 10.1097/DAD.0000000000001819.
引用本文的文献
1
COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review.
Cureus. 2024 Apr 4;16(4):e57587. doi: 10.7759/cureus.57587. eCollection 2024 Apr.
2
COVID-19 infection leading to acute pustular dermatoses.
Arch Dermatol Res. 2023 May;315(4):685-697. doi: 10.1007/s00403-022-02450-z. Epub 2022 Nov 1.
3
Acute generalized exanthematous pustulosis: a complication of COVID-19 infection or therapy?
J Cosmet Dermatol. 2022 May;21(5):1784-1787. doi: 10.1111/jocd.14930. Epub 2022 Apr 5.
4
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.
J Clin Med. 2022 Jan 13;11(2):397. doi: 10.3390/jcm11020397.
5
Severe and life-threatening COVID-19-related mucocutaneous eruptions: A systematic review.
Int J Clin Pract. 2021 Dec;75(12):e14720. doi: 10.1111/ijcp.14720. Epub 2021 Sep 28.
6
Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test.
Contact Dermatitis. 2021 Sep;85(3):366-368. doi: 10.1111/cod.13857. Epub 2021 Apr 23.
7
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
Dermatol Ther. 2021 Jan;34(1):e14662. doi: 10.1111/dth.14662. Epub 2020 Dec 26.
8
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.
J Allergy Clin Immunol. 2020 Oct;146(4):786-789. doi: 10.1016/j.jaci.2020.07.008. Epub 2020 Jul 22.
本文引用的文献
1
Cutaneous manifestations in COVID-19: a first perspective.
J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213. doi: 10.1111/jdv.16387.
2
Acute generalized exanthematous pustulosis: a case series of 13 patients in Brazil.
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e52-e55. doi: 10.1111/jdv.15175. Epub 2018 Jul 31.
3
Recent advances in the understanding of severe cutaneous adverse reactions.
Br J Dermatol. 2017 Nov;177(5):1234-1247. doi: 10.1111/bjd.15423. Epub 2017 Sep 29.
4
Drug reaction with eosinophilia and systemic symptoms during primary Epstein-Barr virus infection.
J Microbiol Immunol Infect. 2015 Feb;48(1):109-12. doi: 10.1016/j.jmii.2014.06.012. Epub 2014 Jul 26.
5
Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern.
J Cutan Pathol. 2001 Mar;28(3):113-9. doi: 10.1034/j.1600-0560.2001.028003113.x.
Zotero 插件